Neuren Pharmaceuticals | NEU - Equity Capital And Reserves


Neuren Pharmaceuticals reported AUD338.45M in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Clinuvel Pharmaceuticals AUD 249.02M 8.21M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Genetic Signatures AUD 44.09M 6M Dec/2025
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
Medical Developments International AUD 54.77M 335K Dec/2025
Neuren Pharmaceuticals AUD 338.45M 15.18M Dec/2025
Organon & Co USD 903M 151M Mar/2026
Paradigm Biopharmaceuticals AUD 6M 15.18M Dec/2025
PYC Therapeutics AUD 147.18M 22.82M Dec/2025
Starpharma Holdings AUD 21.48M 2.48M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Telix Pharmaceuticals AUD 416.86M 5.08M Dec/2025
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026